American College of Cardiology Pushing COVID-19 Vaccines

Organization Endorses Heart Damage as a Necessary Price to Pay

By Peter A. McCullough, MD, MPH

I have been impressed with the lockstep of medical organizations supporting COVID-19 mass vaccination at all costs since December 10, 2020 to the present day. With record rates of myocarditis and a multitude of reports indicating skyrocketing cardiac arrests, one would think the American College of Cardiology would draw concerns over the new genetic products which have an FDA warning for myocarditis.

Before COVID-19, it was well known in the field of cardiology, that exercise in the setting of myocarditis could trigger cardiac arrest. However, like so many aspects of COVID-19 vaccine injury syndromes, acute COVID-19 vaccine myocarditis is obscured in the 2022 ACC Expert Consensus Decision Pathway on Cardiovascular Sequelae of COVID-19 in Adults: Myocarditis and Other Myocardial Involvement, Post-Acute Sequelae of SARS-CoV-2 Infection, and Return to Play document. This 40 page document falsely concludes 1) that COVID-19 illness is a larger risk of myocarditis than vaccination, 2) COVID-19 vaccine induced myocarditis is rare, transient, and mild, 3) COVID-19 vaccination should be undertaken despite the risks of heart damage. I found Figure 4 curious since the title is “favorable” risk benefit profile yet it shows the risks of myocarditis are heavier even with falsely low incidence estimates compared to theoretical vaccine reductions in SARS-CoV-2 hospitalization and death never shown in randomized trials.

I recently wrote the members of the committee I personally know and have been with on prior ACC writing committees. I wanted them to know my concerns as a senior cardiologist about fatal COVID-19 vaccine induced myocarditis as published by Hulscher et al, 2023.